menu
    • menu

    Company profile for Biodexa Pharmaceuticals

    NEW Drugs in Dev: 4
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Biodexa Pharmaceuticals PLC (listed on NASDAQ: BDRX) is a clinical-stage biopharmaceutical company developing a pipeline of products aimed at primary and metastatic cancers of the brain. The company combines approved and development medications with its proprietary and innovative drug delivery technologies to provide compelling products that have the potential to powerfully impact the lives of patients. The Company’s lead ca...
    Biodexa Pharmaceuticals PLC (listed on NASDAQ: BDRX) is a clinical-stage biopharmaceutical company developing a pipeline of products aimed at primary and metastatic cancers of the brain. The company combines approved and development medications with its proprietary and innovative drug delivery technologies to provide compelling products that have the potential to powerfully impact the lives of patients. The Company’s lead candidate, MTX110, is being studied in aggressive rare/orphan brain cancer indications including recurrent glioblastoma, medulloblastoma and paediatric diffuse midline glioma.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Biodexa Pharmaceuticalsunitedkingdom_new Flag
    Country
    Country
    United Kingdom
    Address
    Address
    1 Caspian Point Caspian Way Cardiff CF10 4DQ
    Telephone
    Telephone
    +44 (0)2920480180
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://biodexapharma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/biodexa/?originalSubdomain=uk
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/biodexa_pharma

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    IPhEB Russia

    Not Confirmed

    envelop Contact Supplier

    IPhEB Russia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Preliminary Results for the Year Ended 31 December 2025
    Preliminary Results for the Year Ended 31 December 2025

    27 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/27/3264117/0/en/Preliminary-Results-for-the-Year-Ended-31-December-2025.html

    GLOBENEWSWIRE
    27 Mar 2026
    Share Share
    Biodexa Launches Global Early Access Program for eRapa in FAP
    Biodexa Launches Global Early Access Program for eRapa in FAP

    23 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/23/3260365/0/en/Biodexa-Launches-Global-Early-Access-Program-for-eRapa-for-FAP-Patients-Through-Strategic-Partnership-with-Tanner-Pharma-Group.html

    GLOBENEWSWIRE
    23 Mar 2026
    Share Share
    ADR Ratio Adjustment Takes Effect
    ADR Ratio Adjustment Takes Effect

    18 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/18/3258642/0/en/ADR-Ratio-Change.html

    GLOBENEWSWIRE
    18 Mar 2026
    Share Share
    Biodexa Backs 'Life's a Polyp,' First U.S. FAP Group
    Biodexa Backs 'Life's a Polyp,' First U.S. FAP Group

    09 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/09/3251809/0/en/Biodexa-Announces-Support-for-Life-s-a-Polyp-Foundation-First-U-S-Patient-Advocacy-Group-for-FAP-Patients.html

    GLOBENEWSWIRE
    09 Mar 2026
    Share Share
    Biodexa Licenses P 1 Drug Candidate from Otsuka for Rare Cancer
    Biodexa Licenses P 1 Drug Candidate from Otsuka for Rare Cancer

    20 Feb 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-02-19/biodexa-licenses-phase-1-ready-drug-candidate-from-otsuka-for-rare-stomach-cancer

    PHARMIWEB
    20 Feb 2026
    Share Share
    Biodexa Announces Exclusive License of Otsuka’s OPB-171775
    Biodexa Announces Exclusive License of Otsuka’s OPB-171775

    06 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/04/3232031/0/en/Biodexa-Announces-Exclusive-License-of-Otsuka-s-OPB-171775-a-potent-Phase-1-ready-Molecular-Glue-for-GIST.html

    GLOBENEWSWIRE
    06 Feb 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search